SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-063366
Filing Date
2019-11-13
Accepted
2019-11-13 16:43:45
Documents
16
Period of Report
2019-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922692-1_8k.htm   iXBRL 8-K 43310
2 EXHIBIT 1.1 tm1922692d1_ex1-1.htm EX-1.1 360749
3 EXHIBIT 99.1 tm1922692d1_ex99-1.htm EX-99.1 14380
4 GRAPHIC tm1922692d1_ex99-1img01.jpg GRAPHIC 3325
  Complete submission text file 0001104659-19-063366.txt   729623

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA abbv-20191112.xsd EX-101.SCH 4481
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20191112_def.xml EX-101.DEF 29923
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20191112_lab.xml EX-101.LAB 41913
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20191112_pre.xml EX-101.PRE 28126
14 EXTRACTED XBRL INSTANCE DOCUMENT tm1922692-1_8k_htm.xml XML 9939
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 191214579
SIC: 2834 Pharmaceutical Preparations